Connect with us

Legal & Regulation

Congressional Bill on Hemp-CBD Supplementation Makes Way to the House



Congressional Bill on Hemp-CBD Supplementation Makes Way to the House

On Monday, Representatives Kurt Schrader (D-OR) and Morgan Griffith (R-VA) introduced HR 8179 in the House. The legislation’s short title is “Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.” The legislation concerns the marketability of hemp and hemp-derived CBD as dietary supplements. According to the informational page on the legislation, the “official” title is,

“To make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement, and for other purposes.”

Congressman Griffith issued a press release after introducing the legislation. In the press release, he states:

“Hemp was historically an important crop for Virginia farmers, and dietary supplements made from it do not possess dangerous addictive qualities. Nevertheless, the current state of regulation creates confusion about its legal uses. I joined this bipartisan bill to provide certainty for hemp farmers that their crop may find legal uses.”

It appears that the legislation’s introduction arises from the lack of a regulatory framework at the federal level – particularly by the Food and Drug Administration. The American Herbal Products Association (AHPA), Consumer Healthcare Products Association (CHPA), Council for Responsible Nutrition (CRN), and United Natural Products Alliance (UNPA) shared in a September 8, 2020 press release their support of the legislation, stating:

“While the 2018 Farm Bill changed the law to allow hemp farming, regulatory uncertainty remains about the inclusion of hemp and hemp derived CBD in dietary supplements. This lack of regulatory clarity along with insufficient oversight around hemp and hemp derived CBD exposes consumers to potentially unsafe products and lack of consistency in product quality.”

The press release continues:

“Today’s legislation would allow hemp and hemp derived CBD to be legally marketed in dietary supplements so long as manufacturers comply with new dietary ingredient requirements and other Food and Drug Act dietary supplement policies. This pathway for hemp and hemp derived CBD products to be legally marketed, would put in place necessary safeguards to protect public health. A legal hemp and hemp derived CBD pathway would also provide much needed certainty to hemp farmers.”

Others also appear to support the legislation, particularly due to the FDA’s large inaction on developing a regulatory framework for hemp-derived CBD products. For instance, Julia Gustafson, the Vice President of Government Relations at CRN stated in a September 4, 2020 press release issued by the company:

“Over one year has passed since FDA held its public meeting to better understand hemp-derived substances, and almost two years have passed since the Farm Bill was enacted, legalizing hemp-derived CBD,” said Ms. Gustafson. “During this time, the agency has taken no action to legalize this ingredient, facilitating an unregulated marketplace. CRN urges Congress to pass this critical legislation and open the marketplace to CBD dietary supplements, providing FDA enforcement authority over the category to assure consumers have access to safe and beneficial products to support their health and wellness.”

One question that arises is the chance of a relatively quick passage of the bill. Jonathan Miller, the general counsel for the US Hemp Roundtable, shared with NutraIngredients-USA that his organization is realistic about the prospects of the bill, and intends to develop additional bipartisan support in the coming months. He also added,

“We see a Senate bill in the next few months, and we believe that will include food and beverage.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Charnell Lock lives in sunny San Diego but is originally from North Carolina and has been writing professionally since 2011. After four years with the Navy and an Associate's Degree in Liberal Arts, Charnell found her passion in creating diverse content with well-formatted research. Along with her years in active duty service, she is capable of crafting whimsical short stories to medical-oriented papers as her capacity to contribute here is immense and will be a staple for many years to come.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.